FDA Approved: INDOCIN — Supplemental Application (Zyla Life Sciences US LLC)

View source ↗

Summary

FDA approved a supplemental application for Indocin (indomethacin) submitted by Zyla Life Sciences US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Bursitis
• Gout
• Osteoarthritis
• Patent Ductus Arteriosus
• Rheumatoid Arthritis
• Tendinitis

Drugs mentioned

• INDOCIN (INDOMETHACIN)

Snippet

SUPPL AP for INDOCIN (INDOMETHACIN)